Dose Escalation and Remission (DEAR)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gastroenterology Group of Naples
Naples, Florida, United States
- Shafran Gastroenterology Center
Winter Park, Florida, United States
- Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Chevy Chase Clinical Research
Chevy Chase, Maryland, United States
- Minnesota Gastroenterology, P.A.
Plymouth, Minnesota, United States
- South Jersey Gastroenterology
Marlton, New Jersey, United States
- University of Pennsylvania - Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 31 Jan 2013
- Completion
- 31 Jan 2013
- Last update posted
- 5 May 2015
- Registered enrollment
- 119
- Registry id
- NCT00652145
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.